drugset / Trial / NCT01131377

Acetazolamide Facilitates Ventilator Weaning

NCT01131377

Unknown 150 enrolled Asan Medical Center
RandomizedParallel-groupTriple-blindTreatment

Summary

Metabolic alkalosis(MA) is common metabolic disorder in ICU setting. MA could be cause of weaning failure or delay by depression of respiratory center. The purpose of this study is to evaluate that correction of MA by administration of acetazolamide facilitates weaning of mechanical ventilation.

Timeline

Start
2010-05
Primary completion
2011-05
Completion
2011-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Acetazolamide Small molecule 500 mg Intravenous